Short answer
Thermo Fisher Scientific (TMO) filed an 8-K current report with the SEC on April 23, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Q1 fiscal 2026 results announced April 23, 2026, covering quarter ended March 28, 2026.
Thermo Fisher Scientific 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 fiscal 2026 results announced April 23, 2026, covering quarter ended March 28, 2026
- Full financial results and management commentary furnished in Exhibit 99.1
- Results furnished under Regulation FD, limiting Section 18 liability and automatic incorporation into other filings
Item EX-99.1 · Exhibit EX-99.1
- Q1 revenue $11.01B, up 6%; organic growth only 1%, with acquisitions contributing 3% and currency 2%
- GAAP diluted EPS $4.43, up 11%; adjusted EPS $5.44, up 6%
- GAAP operating margin improved to 16.9% from 16.6%, while adjusted margin slipped to 21.8% from 21.9%
- Clario acquisition drove $8.872B cash outflow and increased long-term obligations to $40.071B from $35.852B
- Capital returns remained substantial: $3.0B stock repurchases and dividend increased 10% during the quarter
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Thermo Fisher Scientific 8-K filings
Get the next TMO 8-K as it lands
Follow TMO for push alerts, or ask the research agent what this filing means.